NCT06389786 2026-04-06Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate CancerMayo ClinicPhase NA Recruiting50 enrolled
NCT07025369 2026-03-13Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA TrialMayo ClinicPhase 2 Recruiting30 enrolled